{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T17:52:32Z","timestamp":1766339552034},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1007\/s11906-002-0067-5","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T20:11:30Z","timestamp":1180123890000},"page":"377-380","source":"Crossref","is-referenced-by-count":43,"title":["Hypertensinogenic mechanism of the calcineurin inhibitors"],"prefix":"10.1007","volume":"4","author":[{"given":"John J.","family":"Curtis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"67_CR1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01973261","volume":"6","author":"JF Borel","year":"1976","unstructured":"Borel JF, Feurer C, Gubler HU, et al.: Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 1976, 6:468\u2013475. This is a historic article worthy of reading, which demonstrates how findings at the bench and in rat models eventually find themselves transferred to the bedside. Of special interest are the observations (speculations) that Borel had about the mechanism of action of cyclosporine.","journal-title":"Agents Actions"},{"key":"67_CR2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(79)92440-1","volume":"2","author":"R Calne","year":"1979","unstructured":"Calne R, Rolles K, White DJ, et al.: Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs. Lancet 1979, 2:1033\u20131036. This article describes a not-so-good experience in humans with cyclosporine. However, it was an experience with 34 patients that prompted further study by Starzl et al. [4].","journal-title":"Lancet"},{"issue":"Suppl 1","key":"67_CR3","first-page":"S193","volume":"25","author":"B Ryffel","year":"1986","unstructured":"Ryffel B, Siegl H, Petric R, et al.: Nephrotoxicity of cyclosporine in spontaneously hypertensive rats: effects on blood pressure and vascular lesions. Clin Nephrol 1986, 25(Suppl 1):S193-S198.","journal-title":"Clin Nephrol"},{"key":"67_CR4","first-page":"17","volume":"151","author":"TE Starzl","year":"1980","unstructured":"Starzl TE, Weil R, Iwatsuki S, et al.: The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet 1980, 151:17\u201326.","journal-title":"Surg Gynecol Obstet"},{"key":"67_CR5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/0002-9343(84)90356-5","volume":"77","author":"AG Palestine","year":"1984","unstructured":"Palestine AG, Nussenblatt RB, Chan CC: Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med 1984, 77:652\u2013656. This study established the undesired effects and nephrotoxicity of cyclosporine in a group of nontransplant patients. Prior consideration of side effects in transplanted patients could never be as certain of the causal role of cyclosporine because of other drugs and other renal conditions.","journal-title":"Am J Med"},{"key":"67_CR6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev.me.37.020186.001243","volume":"37","author":"WM Bennett","year":"1986","unstructured":"Bennett WM, Norman DJ: Action and toxicity of cyclosporine. Ann Rev Med 1986, 37:215\u2013224.","journal-title":"Ann Rev Med"},{"key":"67_CR7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0002-9343(88)80331-0","volume":"85","author":"JJ Curtis","year":"1988","unstructured":"Curtis JJ, Luke RG, Jones PA, et al.: Hypertension in cyclosporine- treated renal transplant recipients is sodium dependent. Am J Med 1988, 85:134\u2013138. This report suggests that sodium sensitivity is related to hypertension induced by cyclosporine. It does not appear that systemic plasma renin activity is a mediator.","journal-title":"Am J Med"},{"key":"67_CR8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00007890-198912000-00014","volume":"48","author":"B Kiberd","year":"1989","unstructured":"Kiberd B: Cyclosporine-induced renal dysfunction in human renal allograft recipients. Transplantation 1989, 48:965\u2013969.","journal-title":"Transplantation"},{"key":"67_CR9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0002-9343(88)80330-9","volume":"85","author":"W Bennett","year":"1988","unstructured":"Bennett W, Porter G: Cyclosporine-associated hypertension. Am J Med 1988, 85:131\u2013133.","journal-title":"Am J Med"},{"key":"67_CR10","first-page":"404","volume":"4","author":"J Rottembourg","year":"1985","unstructured":"Rottembourg J, Mattei MF, Cabrol A, et al.: Renal function and blood pressure in heart transplant recipients treated with cyclosporine. J Heart Transplant 1985, 4:404\u2013408.","journal-title":"J Heart Transplant"},{"key":"67_CR11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-2133.1998.02122.x","volume":"138","author":"AV Powles","year":"1998","unstructured":"Powles AV, Hardman CM, Porter WM, et al.: Renal function after 10 years\u2019 treatment with cyclosporin for psoriasis. Br J Dermatol 1998, 138:443\u2013449.","journal-title":"Br J Dermatol"},{"key":"67_CR12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2133.1994.tb13111.x","volume":"130","author":"T Joost van","year":"1994","unstructured":"van Joost T, Heule F, Korstanje M, et al.: Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study. Br J Dermatol 1994, 130:634\u2013640.","journal-title":"Br J Dermatol"},{"key":"67_CR13","first-page":"1108","volume":"14","author":"P Tugwell","year":"1987","unstructured":"Tugwell P, Bombardier C, Gent M, et al.: Low dose cyclosporine in rheumatoid arthritis: a pilot study. J Rheumatol 1987, 14:1108\u20131114.","journal-title":"J Rheumatol"},{"issue":"Suppl 8","key":"67_CR14","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1681\/ASN.V48s10","volume":"4","author":"DE Hricik","year":"1994","unstructured":"Hricik DE, Kupin WL, First MR: Steroid-free immunosuppression after renal transplantation. J Am Soc Nephrol 1994, 4(Suppl 8):S10-S16.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"67_CR15","first-page":"H1791","volume":"261","author":"M Carrier","year":"1991","unstructured":"Carrier M, Tronc F, Stewart D, et al.: Dose-dependent effect of cyclosporin on renal arterial resistance in dogs. Am J Physiol 1991, 261(6 Pt 2):H1791-H1796.","journal-title":"Am J Physiol"},{"key":"67_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/17843286.1989.11718031","volume":"44","author":"J Plaen De","year":"1989","unstructured":"De Plaen J, Ferrant A, Michaux JL, et al.: Hypertension in bone marrow transplanted patients. Acta Clin Belg 1989, 44:295\u2013302.","journal-title":"Acta Clin Belg"},{"key":"67_CR17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00007890-198601000-00009","volume":"41","author":"C June","year":"1986","unstructured":"June C, Thompson C, Kennedy MS, et al.: Correlation of hypomagnesemia with the onset of cyclosporine-associated hypertension in marrow transplant patients. Transplantation 1986, 41:47\u201351.","journal-title":"Transplantation"},{"key":"67_CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00007890-198707000-00027","volume":"44","author":"J English","year":"1987","unstructured":"English J, Evan A, Houghton DC, et al.: Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation 1987, 44:135\u2013141. This study is a classic example of a picture being worth 1000 words. The graphic appearance of cyclosporine on the pre- and postglomerular vessels is shown in dramatic fashion.","journal-title":"Transplantation"},{"key":"67_CR19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199009133231101","volume":"323","author":"U Scherrer","year":"1990","unstructured":"Scherrer U, Vissing SF, Morgan BJ, et al.: Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990, 323:693\u2013699.","journal-title":"N Engl J Med"},{"key":"67_CR20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0272-6386(12)81015-8","volume":"23","author":"JJ Curtis","year":"1994","unstructured":"Curtis JJ: Hypertension following kidney transplantation. Am J Kidney Dis 1994, 23:471\u2013475.","journal-title":"Am J Kidney Dis"},{"key":"67_CR21","first-page":"417","volume":"43","author":"C Baxter","year":"1984","unstructured":"Baxter C, Duggin C, Hall BM, et al.: Stimulation of renin release from rat renal cortical slices by cyclosporin A. Res Commun Chem Pathol Pharmacol 1984, 43:417\u2013423.","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"67_CR22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ki.1989.29","volume":"35","author":"DC Lau","year":"1989","unstructured":"Lau DC, Wong KL, Hwang WS: Cyclosporine toxicity on cultured rat microvascular endothelial cells. Kidney Int 1989, 35:604\u2013613.","journal-title":"Kidney Int"},{"key":"67_CR23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.HYP.13.4.352","volume":"13","author":"H Meyer-Lehnert","year":"1989","unstructured":"Meyer-Lehnert H, Schrier RW: Potential mechanism of cyclosporine A-induced vascular smooth muscle contraction. Hypertension 1989, 13:352\u2013360.","journal-title":"Hypertension"},{"key":"67_CR24","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/0024-3205(87)90080-4","volume":"40","author":"FS Lamb","year":"1987","unstructured":"Lamb FS, Webb RC: Cyclosporine augments reactivity of isolated blood vessels. Life Sci 1987, 40:2571\u20132578.","journal-title":"Life Sci"},{"key":"67_CR25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00007890-198705000-00022","volume":"43","author":"H Xue","year":"1987","unstructured":"Xue H, Bukoski RD, McCarron DA, et al.: Induction of contraction in isolated rat aorta by cyclosporine. Transplantation 1987, 43:715\u2013718.","journal-title":"Transplantation"},{"key":"67_CR26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/ndt\/9.5.552","volume":"9","author":"C Pouteil-Noble","year":"1994","unstructured":"Pouteil-Noble C, Chapuis F, Berra N, et al.: Misoprostol in renal transplant recipients: a prospective, randomized, controlled study on the prevention of acute rejection episodes and cyclosporin A nephrotoxicity. Nephrol Dial Transplant 1994, 9:552\u2013555.","journal-title":"Nephrol Dial Transplant"},{"key":"67_CR27","first-page":"634","volume":"20","author":"MS Paller","year":"1988","unstructured":"Paller MS: The prostaglandin E1 analog misoprostol reverses acute cyclosporine nephrotoxicity. Transplant Proc 1988, 20:634\u2013637.","journal-title":"Transplant Proc"},{"key":"67_CR28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00007890-199209000-00038","volume":"54","author":"ME Wilkie","year":"1992","unstructured":"Wilkie ME, Beer JC, Newman D, et al.: Evidence that the risks of misoprostol outweigh its benefits in stable cyclosporinetreated renal allograft recipients. Transplantation 1992, 54:565\u2013567.","journal-title":"Transplantation"},{"key":"67_CR29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000174109","volume":"20","author":"YJ Kim","year":"1997","unstructured":"Kim YJ, Park YH, Moon HK: Reduction of chronic ciclosporin nephrotoxicity by thromboxane synthase inhibition with OKY-046. Kidney Blood Press Res 1997, 20:38\u201343.","journal-title":"Kidney Blood Press Res"},{"key":"67_CR30","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0002-9149(91)90545-V","volume":"67","author":"BS Edwards","year":"1991","unstructured":"Edwards BS, Hunt SA, Fowler MB, et al.: Effect of cyclosporine on plasma endothelin levels in humans after cardiac transplantation. Am J Cardiol 1991, 67:782\u2013784.","journal-title":"Am J Cardiol"},{"key":"67_CR31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ki.1987.166","volume":"32","author":"E Barros","year":"1987","unstructured":"Barros E, Boim M, Ajzen H, et al.: Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. Kidney Int 1987, 32:19\u201325.","journal-title":"Kidney Int"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-002-0067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-002-0067-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-002-0067-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T07:14:52Z","timestamp":1628925292000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-002-0067-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["67"],"URL":"https:\/\/doi.org\/10.1007\/s11906-002-0067-5","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}